Gregory Jackson v. HHS - Tdap, Guillain-Barré Syndrome (GBS) (2022)
Case summary [AI summaries can sometimes make mistakes]
Gregory Jackson filed a petition on July 2, 2018, alleging that he suffered Guillain-Barré Syndrome (GBS) as a result of a tetanus-diphtheria-acellular pertussis (Tdap) vaccine he received on May 18, 2017. The respondent denied that the vaccine caused Petitioner's alleged GBS or any other injury, and denied that his current condition was a sequela of a vaccine-related injury.
The parties reached a stipulation recommending an award of compensation. Special Master Nora Beth Dorsey adopted the stipulation as the decision of the Court.
The stipulation provided for compensation in the amount of $160,000.00 in the form of a check payable to Petitioner, representing all damages available under 42 U.S.C. § 300aa-15(a). The parties agreed to waive their right to seek review, and judgment was entered accordingly.
The public decision does not describe the onset of symptoms, specific medical tests, treatments, or expert witnesses. Petitioner's counsel was Renee Ja Gentry, and respondent's counsel was Ronalda Elnetta Kosh.
Theory of causation
Petitioner Gregory Jackson alleged that a Tdap vaccine received on May 18, 2017, caused Guillain-Barré Syndrome (GBS). The respondent denied causation. The parties reached a stipulation for compensation, which was adopted by Special Master Nora Beth Dorsey. The stipulation awarded Petitioner $160,000.00 for all damages. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury. The case was resolved via stipulation, with judgment entered upon waiver of the right to seek review.
Source PDFs
USCOURTS-cofc-1_18-vv-00949